Stay updated with breaking news from Vstm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $8.16 and traded as high as $11.18. Verastem shares last traded at $10.22, with a volume of 294,116 shares changing hands. Analysts Set New Price Targets A number of […]
Shares of Verastem, Inc. (NASDAQ:VSTM – Get Free Report) have received an average recommendation of “Buy” from the six analysts that are presently covering the stock, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have updated their coverage on the stock in the […]
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) has earned a consensus rating of “Buy” from the six brokerages that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have issued ratings on the stock in the last […]
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) was the target of a large decrease in short interest in July. As of July 15th, there was short interest totalling 241,600 shares, a decrease of 19.5% from the June 30th total of 300,000 shares. Currently, 1.0% of the company’s shares are sold short. Based on an average […]
Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. The firm currently has $36.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $24.00. Several other research firms have also recently weighed […]